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It’s now cheaper to print color figures in KI
Have you been concerned in the past about the cost of print-
ing color figures in Kidney International (KI)? KI has listened 
to your concerns and is now offering permanently reduced 
pricing for color figures—a flat fee of $500 per printed page, 
no matter how many color figures are on a page. This pricing 
is more affordable for authors and competitive with other top 
scientific journals. We want to make it easier for authors to 
publish the color figures that demonstrate important scien-
tific findings, and our new pricing reflects our commitment to 
achieving this goal.
Syndecan protects 
tubular cells
Optimal recovery from acute kidney 
injury depends on the ability of renal 
epithelial cells to limit the extent of 
ischemic and inflammatory injury and 
to rapidly proliferate to replace lost cells. 
As they report in this issue, Celie et al. 
studied whether expression of synde-
can-1, a heparan sulfate proteoglycan 
with an important role in wound heal-
ing, is important for protecting renal 
epithelial cells and potentiating recov-
ery from ischemia/reperfusion injury 
in the setting of renal transplantation. 
The investigators found that increased 
syndecan-1 expression was associated 
with improved renal allograft outcomes 
in patients. Moreover, using in vitro 
and in vivo models of ischemia/reper-
fusion injury, they demonstrated that 
loss of syndecan-1 expression worsens 
renal epithelial injury and inflammation 
while reducing epithelial proliferation. 
See page 651.
Is BOLD-MRI useful  
in CKD?
Blood oxygen level–dependent magnetic 
resonance imaging (BOLD-MRI) has 
been touted as a promising diagnostic test 
that can provide clinicians with accurate 
noninvasive information regarding glo-
merular filtration rate (GFR) and tissue 
oxygenation. This method might serve 
as a surrogate for renal fibrosis. Michaely 
et al. examined 400 patients with vary-
ing levels of renal function to determine 
whether renal cortical or medullary oxy-
genation as analyzed by BOLD-MRI dif-
fered according to the level of estimated 
GFR. The authors report that renal 
oxygenation was not correlated with 
patients’ sex, age, estimated GFR, or stage 
of chronic kidney disease (CKD). These 
findings demonstrate that patients with 
reduced GFR do not necessarily have 
lower levels of intrarenal oxygenation as 
determined by BOLD-MRI and that this 
method cannot be used to determine the 
degree of CKD. See page 684.
Vitamin D levels in 
children with CKD
Vitamin D deficiency is increasingly 
recognized as a problem in the general 
population, and especially in CKD. Kalk-
warf et al. now report on the incidence of 
vitamin D deficiency in children, an espe-
cially susceptible population. They found 
that nearly half of 182 patients (ages 5–21 
years) with kidney disease (stages 2–5) 
and a third of 276 age-matched healthy 
children were 25-hydroxyvitamin D defi-
cient. The risk of deficiency increased with 
advancing degrees of CKD. Furthermore, 
focal segmental glomerulosclerosis and 
low albumin were associated with lower 
25-hydroxyvitamin D and higher parathy-
roid hormone levels. Vitamin D levels were 
inversely related to inflammatory markers 
such as C-reactive protein and interleu-
kin-6. Thus, lower 25-hydroxyvitamin D 
may contribute to hyperparathyroidism, 
inflammation, and lower 1,25-dihydroxy-
vitamin D in children and adolescents, 
especially those with advanced kidney 
disease. These findings are of considerable 
consequence for vitamin D administration 
in children. See page 690.
